Bain Capital And Cinven’s CHF 4.2 Billion Acquisition of Lonza’s Specialty Ingredients Business

Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin, Freshfields Bruckhaus Deringer, Kirkland & Ellis and Elvinger Hoss Prussen advised Bain Capital Private Equity and Cinven.

Lonza entered into a definitive agreement with Bain Capital and Cinven to sell Lonza’s Specialty Ingredients business and operations for an enterprise value of CHF 4.2 billion. The divestment will allow Lonza to refocus its business as a pure-play partner to the healthcare industry.

Lonza’s Specialty Ingredients business operates across 17 manufacturing sites globally and has approximately 2,800 permanent employees. The business is a leading provider of microbial control solutions for professional hygiene and personal care products. It also offers the custom development and manufacturing of specialty chemicals and composites to support the electronics, aerospace, food and agrochemical industries. The transaction is anticipated to close in second half of 2021, subject to customary closing conditions.

The Bär & Karrer team included Urs Kägi (Picture), Rolf Watter, Nadina Duss, Michael Bänziger, Matthias Tanner, Susanne Schreiber, Lukas Roesler, Ruth Bloch-Riemer, Laura Widmer, Corrado Rampini, Rocco Rigozzi, Mani Reinert, Thomas Stoltz, Frédéric Mancosu and Markus Wang.

The Lenz & Staehelin team included Tino GaberthüeL, Beat Kühni, Marcel Tranchet, Astrid Waser, Pascal Hinny, Eric Meier, Alex Wille, Xavier Grivel, Lisa Moser, Tobias Weber, Roland Fischer, Kevin MacCabe, Anja Affolter Marino, Leo Rusterholz, Lukas Aebi and David Hitz.

Kirkland & Ellis team included partners Adrian Maguire, Rory Mullarkey, Jacob Traff and Dan Clarke and associates Claire Rushton, Max Mugnaioni, Jelani Okoruwa and Molly Beck; tax partners Tim Lowe and Mike Carew; antitrust & competition partner Paula Riedel and technology & IP transactions associate John Patten.

The Freshfields team was led by partners Aled Batey, Christopher Davis, Denise Ryan and Andrew Hagan.

The Elvinger Hoss Prussen team iincluded partners Toinon Hoss and Azadeh Djazayeri, senior associate David Paiva, and associates Kelly Moulla, Fatima Khaloui and Elisabeth Mans.

 

 

Involved fees earner: Michael Bänziger – Bär & Karrer; Ruth Bloch-Riemer – Bär & Karrer; Nadina Duss – Bär & Karrer; Urs Kägi – Bär & Karrer; Frédéric Mancosu – Bär & Karrer; Corrado Rampini – Bär & Karrer; Mani Reinert – Bär & Karrer; Rocco Rigozzi – Bär & Karrer; Lukas Roesler – Bär & Karrer; Susanne Schreiber – Bär & Karrer; Thomas Stoltz – Bär & Karrer; Matthias Tanner – Bär & Karrer; Markus Wang – Bär & Karrer; Rolf Watter – Bär & Karrer; Laura Widmer – Bär & Karrer; Aled Batey – Freshfields Bruckhaus Deringer LLP; Christopher Davis – Freshfields Bruckhaus Deringer LLP; Andrew Hagan – Freshfields Bruckhaus Deringer LLP; Denise Ryan – Freshfields Bruckhaus Deringer LLP; Molly Beck – Kirkland & Ellis; Mike Carew – Kirkland & Ellis; Dan Clarke – Kirkland & Ellis; Timothy Lowe – Kirkland & Ellis; Adrian Maguire – Kirkland & Ellis; Max Mugnaioni – Kirkland & Ellis; Rory Mullarkey – Kirkland & Ellis; Jelani Okoruwa – Kirkland & Ellis; John Patten – Kirkland & Ellis; Paula Riedel – Kirkland & Ellis; Claire Rushton – Kirkland & Ellis; Jacob Traff – Kirkland & Ellis; Lukas Aebi – Lenz & Staehelin; Anja Affolter Marino – Lenz & Staehelin; Roland Fischer – Lenz & Staehelin; Tino Gaberthüel – Lenz & Staehelin; Xavier Grivel – Lenz & Staehelin; Pascal Hinny – Lenz & Staehelin; David Hitz – Lenz & Staehelin; Beat Kühni – Lenz & Staehelin; Kevin MacCabe – Lenz & Staehelin; Eric Meier – Lenz & Staehelin; Lisa Moser – Lenz & Staehelin; Leo Rusterholz – Lenz & Staehelin; Marcel Tranchet – Lenz & Staehelin; Astrid Waser – Lenz & Staehelin; Tobias Weber – Lenz & Staehelin; Alex Wille – Lenz & Staehelin;

Law Firms: Bär & Karrer; Freshfields Bruckhaus Deringer LLP; Kirkland & Ellis; Lenz & Staehelin;

Clients: Bain Capital; Cinven; Lonza Group AG.;

Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin and Kirkland & Ellis advised Bain Capital Private Equity and Cinven.

Lonza entered into a definitive agreement with Bain Capital and Cinven to sell Lonza’s Specialty Ingredients business and operations for an enterprise value of CHF 4.2 billion. The divestment will allow Lonza to refocus its business as a pure-play partner to the healthcare industry.

Lonza’s Specialty Ingredients business operates across 17 manufacturing sites globally and has approximately 2,800 permanent employees. The business is a leading provider of microbial control solutions for professional hygiene and personal care products. It also offers the custom development and manufacturing of specialty chemicals and composites to support the electronics, aerospace, food and agrochemical industries. The transaction is anticipated to close in second half of 2021, subject to customary closing conditions.

The Bär & Karrer team included Urs Kägi (Picture), Rolf Watter, Nadina Duss, Michael Bänziger, Matthias Tanner, Susanne Schreiber, Lukas Roesler, Ruth Bloch-Riemer, Laura Widmer, Corrado Rampini, Rocco Rigozzi, Mani Reinert, Thomas Stoltz, Frédéric Mancosu and Markus Wang.

The Lenz & Staehelin team included Tino GaberthüeL, Beat Kühni, Marcel Tranchet, Astrid Waser, Pascal Hinny, Eric Meier, Alex Wille, Xavier Grivel, Lisa Moser, Tobias Weber, Roland Fischer, Kevin MacCabe, Anja Affolter Marino, Leo Rusterholz, Lukas Aebi and David Hitz.

Kirkland & Ellis team included partners Adrian Maguire, Rory Mullarkey, Jacob Traff and Dan Clarke and associates Claire Rushton, Max Mugnaioni, Jelani Okoruwa and Molly Beck; tax partners Tim Lowe and Mike Carew; antitrust & competition partner Paula Riedel and technology & IP transactions associate John Patten.

Involved fees earner: Michael Bänziger – Bär & Karrer; Ruth Bloch-Riemer – Bär & Karrer; Nadina Duss – Bär & Karrer; Urs Kägi – Bär & Karrer; Frédéric Mancosu – Bär & Karrer; Corrado Rampini – Bär & Karrer; Mani Reinert – Bär & Karrer; Rocco Rigozzi – Bär & Karrer; Lukas Roesler – Bär & Karrer; Susanne Schreiber – Bär & Karrer; Thomas Stoltz – Bär & Karrer; Matthias Tanner – Bär & Karrer; Markus Wang – Bär & Karrer; Rolf Watter – Bär & Karrer; Laura Widmer – Bär & Karrer; Molly Beck – Kirkland & Ellis; Mike Carew – Kirkland & Ellis; Dan Clarke – Kirkland & Ellis; Timothy Lowe – Kirkland & Ellis; Adrian Maguire – Kirkland & Ellis; Max Mugnaioni – Kirkland & Ellis; Rory Mullarkey – Kirkland & Ellis; Jelani Okoruwa – Kirkland & Ellis; John Patten – Kirkland & Ellis; Paula Riedel – Kirkland & Ellis; Claire Rushton – Kirkland & Ellis; Jacob Traff – Kirkland & Ellis; Lukas Aebi – Lenz & Staehelin; Anja Affolter Marino – Lenz & Staehelin; Roland Fischer – Lenz & Staehelin; Tino Gaberthüel – Lenz & Staehelin; Xavier Grivel – Lenz & Staehelin; Pascal Hinny – Lenz & Staehelin; David Hitz – Lenz & Staehelin; Beat Kühni – Lenz & Staehelin; Kevin MacCabe – Lenz & Staehelin; Eric Meier – Lenz & Staehelin; Lisa Moser – Lenz & Staehelin; Leo Rusterholz – Lenz & Staehelin; Marcel Tranchet – Lenz & Staehelin; Astrid Waser – Lenz & Staehelin; Tobias Weber – Lenz & Staehelin; Alex Wille – Lenz & Staehelin;

Law Firms: Bär & Karrer; Kirkland & Ellis; Lenz & Staehelin;

Clients: Bain Capital; Cinven; Lonza Group AG.;

Federica Tiefenthaler

Author: Federica Tiefenthaler